DeepMed Research

AGN-231868

Generic Name: AGN-231868

Clinical Trials

A Study of the Drugs AGN-242428 and AGN-231868 in Participants With Dry Eye Disease

Phase 1

Completed

Conditions: Dry Eye Syndrome
Dry Eye Disease

Interventions: Drug: AGN-242428
Other: AGN-242428 Vehicle
Drug: AGN-231868
Other: AGN-231868 Vehicle
Drug: Lifitegrast 5% Ophthalmic Solution

First Posted Date: 2019-07-24

Last Posted Date: 2025-05-20

Lead Sponsor: AbbVie

Target Recruit Count: 292

Registration Number: NCT04030962

Locations: 🇺🇸
Duplicate_Alpine Research Organization, Inc. /ID# 240508, Clinton, Utah, United States
🇺🇸
Cornea and Cataract Consultants of Arizona /ID# 232769, Phoenix, Arizona, United States
🇺🇸
The Eye Research Foundation /ID# 232696, Newport Beach, California, United States

and more 8 locations

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy